Careers.

Opportunities from the partner universities and the wider MICRA ecosystem

A woman scientist looks into a microscope. She is in a research setting with scales on the counter next to her and she looks into a white microscope with numerous black lenses one of which she is adjusting with a blue plastic goloved hand. The woman is of a white ethnicity, in her 30s, has a small just about visible nose ring, curly red hair and freckles, she wear a white lab coat

Birmingham spinout Revitope Oncology Inc announces $10m investment

December 16, 2020: University of Birmingham spinout Revitope Oncology Inc has announced a $10m investment from leading Chinese biopharmaceutical company Junshi Biosciences.

FIND OUT MORE

Photo shows an iPhone with different screens from the Oro app loaded on it. The iPhone is a gold/mustard yellow case reflecting the background to the picture which is the same colour, as is the primary colour scheme for the app as displayed on the screen

Loughborough Uni Partners with Holland & Barrett to Develop new Oro health App

Experts at Loughborough University have teamed up with the UK’s leading health and wellbeing store, Holland and Barrett, to create a unique personalised health and fitness app.

FIND OUT MORE

Conceptual graphical representation of NanonSyrinx's technology working to attack a biological threat in someone's body

Warwick spin-out NanoSyrinx appoints Dr Jane Dancer as Non-Exec Director

NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director.

FIND OUT MORE

Catapult Ventures invests in Warwick Spin-out OVO Biomanufacturing improving the manufacturing efficiency of viral vaccines & gene therapies

OVO Biomanufacturing has announced the completion of a new funding round to develop its novel technology platform to improve the manufacturing efficiency for viral vaccines and gene therapies.

FIND OUT MORE

Picture of two of the NanoSyrinx founders. Both are white men, one in his fifties the other in his thirties. They are in a laboratory setting, wearing blue overalls and leaning on a work bench to look at a laptop screen which displays a 3d graphic

Warwick spin-out NanoSyrinx secures capital for its customisable intra-cellular engineering platform

NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures, the corporate venture capital arm of Merck. BioCity (Nottingham, United Kingdom) and UK Innovation & Science Seed Fund also participated in the financing.

FIND OUT MORE

Neonatal Medtech Spin-Out from the University of Nottingham Scoops £1million Investment

Tags Date Posted Posted By Midlands Innovation Commercialisation of Research Accelerator (MICRA) partner institution the University of Nottingham, have welcomed the news that one of

FIND OUT MORE